Wen Shuo (Marco) Wu
Senior Director Medical Late Phase Clinical Development, Immunology Business Unit @ Eli Lilly and Company
About Wen Shuo (Marco) Wu
Wen Shuo (Marco) Wu serves as the Senior Director of Medical Late Phase Clinical Development in the Immunology Business Unit at Eli Lilly and Company, a position he has held since 2022. With extensive experience in clinical research and medical leadership, he has contributed to the launch of several medications for autoimmune diseases and has a background in pulmonology.